IL302394A - Peptides and methods of use - Google Patents
Peptides and methods of useInfo
- Publication number
- IL302394A IL302394A IL302394A IL30239423A IL302394A IL 302394 A IL302394 A IL 302394A IL 302394 A IL302394 A IL 302394A IL 30239423 A IL30239423 A IL 30239423A IL 302394 A IL302394 A IL 302394A
- Authority
- IL
- Israel
- Prior art keywords
- seq
- rls
- peptides
- peptide
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063108732P | 2020-11-02 | 2020-11-02 | |
| PCT/US2021/057504 WO2022094372A1 (en) | 2020-11-02 | 2021-11-01 | Peptides and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL302394A true IL302394A (en) | 2023-06-01 |
Family
ID=81384399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL302394A IL302394A (en) | 2020-11-02 | 2021-11-01 | Peptides and methods of use |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230272012A1 (de) |
| EP (1) | EP4236983A4 (de) |
| JP (1) | JP7804672B2 (de) |
| KR (1) | KR20230095112A (de) |
| CN (1) | CN116528886A (de) |
| AU (1) | AU2021372544A1 (de) |
| CA (1) | CA3194446A1 (de) |
| IL (1) | IL302394A (de) |
| MX (1) | MX2023005135A (de) |
| WO (1) | WO2022094372A1 (de) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2626182T3 (es) * | 2010-07-21 | 2017-07-24 | Eastern Virginia Medical School | Compuestos peptídicos para regular el sistema del complemento |
| US10005818B2 (en) | 2010-07-21 | 2018-06-26 | Realta Holdings, Llc | Derivative peptide compounds and methods of use |
| ES2875498T3 (es) * | 2015-06-26 | 2021-11-10 | Realta Holdings Llc | Compuestos de péptidos sintéticos y procedimientos de uso |
| CA3086407A1 (en) | 2018-01-09 | 2019-07-18 | Realta Holdings, Llc | Pic1 inhibition of myeloperoxidase oxidative activity in an animal model |
| AU2019218786B2 (en) | 2018-02-07 | 2024-05-02 | Dana-Farber Cancer Institute, Inc. | Cell-permeable stapled peptide modules for cellular delivery |
| WO2019236658A2 (en) | 2018-06-06 | 2019-12-12 | Eastern Virginia Medical School | Pic1 peptide compositions and methods of use thereof for treatment of drug-induced immune hemolytic anemia |
| WO2020168036A1 (en) | 2019-02-15 | 2020-08-20 | Eastern Virginia Medical School | Pic1 variants with improved solubility and methods of using the same |
-
2021
- 2021-11-01 AU AU2021372544A patent/AU2021372544A1/en active Pending
- 2021-11-01 CN CN202180073739.3A patent/CN116528886A/zh active Pending
- 2021-11-01 US US18/034,731 patent/US20230272012A1/en active Pending
- 2021-11-01 EP EP21887700.9A patent/EP4236983A4/de active Pending
- 2021-11-01 WO PCT/US2021/057504 patent/WO2022094372A1/en not_active Ceased
- 2021-11-01 JP JP2023526544A patent/JP7804672B2/ja active Active
- 2021-11-01 CA CA3194446A patent/CA3194446A1/en active Pending
- 2021-11-01 IL IL302394A patent/IL302394A/en unknown
- 2021-11-01 MX MX2023005135A patent/MX2023005135A/es unknown
- 2021-11-01 KR KR1020237018153A patent/KR20230095112A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3194446A1 (en) | 2022-05-05 |
| US20230272012A1 (en) | 2023-08-31 |
| MX2023005135A (es) | 2023-05-26 |
| EP4236983A1 (de) | 2023-09-06 |
| EP4236983A4 (de) | 2024-12-11 |
| AU2021372544A1 (en) | 2023-05-18 |
| JP2023548344A (ja) | 2023-11-16 |
| KR20230095112A (ko) | 2023-06-28 |
| WO2022094372A1 (en) | 2022-05-05 |
| CN116528886A (zh) | 2023-08-01 |
| JP7804672B2 (ja) | 2026-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6770043B2 (ja) | 補体活性の変調 | |
| KR102220006B1 (ko) | 자가면역 - 관련 또는 염증성 장애를 치료하기 위한 저용량 ｉｌ２ 의 용도 | |
| JP6915034B2 (ja) | 補体活性の変調剤 | |
| US20200397855A1 (en) | Modulation of pla2-g1b in therapy | |
| JP2021514183A (ja) | 改変免疫調節ペプチド | |
| US20230272012A1 (en) | Peptides and methods of use | |
| WO2019236474A1 (en) | Methods of use of cd24 for the prevention and treatment of leukemia relapse | |
| US20230303623A1 (en) | Peptides and methods of use | |
| US20240209036A1 (en) | Peptides and methods of use | |
| US20230414506A1 (en) | Peptide formulations and methods of use | |
| WO2025069022A1 (en) | Immunomodulating peptides and uses thereof | |
| KR20240042017A (ko) | 발현 수준이 증가된 변형된 hla-b57 | |
| CN117396215A (zh) | 肽和使用方法 | |
| CN118043345A (zh) | 包括hla融合蛋白的药物组合物 |